Neuried/Nesle, 8 July 2026 – AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe (AFE), marking a key step in scaling the industrial production of its silk proteins. Building on the collaboration first established in 2023, the two companies have now entered into […]
Hansa Biopharma appointed Adam Cutler as new Chief Financial Officer Hansa Biopharma AB announced the appointment of Adam Cutler as its new Chief Financial Officer (CFO) and member of the Executive Committee, effective June 22, 2026. Adam succeeds Evan Ballantyne, who has served as CFO since 2024. Evan will continue in the role until June […]
Senior executive across industrial biotechnology and consumer markets with strong expertise in commercialization joins AMSilk as the Company advances from development through scale-up to market growth The announcement follows the launch of biotech silk protein yarns in Balenciaga Spring 2026 collection Neuried, Germany, June 17, 2026 – AMSilk GmbH (“AMSilk”), a global leader in advanced […]
First commercially available products using AMSilk’s biotech silk protein yarns Demonstrating a scalable, low impact alternative to conventional silk within luxury fashion Designed for resilient, transparent and regionally integrated supply chains Neuried, Germany, January 21, 2026 – AMSilk GmbH (“AMSilk”), a global leader in advanced biomaterials made from silk proteins, today announced that its bioengineered […]
Dedicated manufacturing line for AMSilk high-performance silk proteins High tech industrial biomaterials meet leading apparel brands’ demand for scalable, sustainable, alternatives Expanding Evonik’s portfolio of precision biosolutions ESSEN, Germany and NEURIED, Germany, Sept. 25, 2025 – Evonik and AMSilk, a global leader in advanced biomaterials based on silk proteins, have deepened their collaboration with a long-term agreement to produce […]
